Gene · 4773
Papers3,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nuclear Factor of Activated T Cells-5 Regulates Notochord Lumenogenesis in Chordate Larval Development. | Int J Mol Sci | 2022 | 36430885 | PubTator, text mining | PubMed |
| SNP-Target Genes Interaction Perturbing the Cancer Risk in the Post-GWAS. | Cancers (Basel) | 2022 | 36428729 | PubTator, text mining | PubMed |
| Role of PARP Inhibitors in Cancer Immunotherapy: Potential Friends to Immune Activating Molecules and Foes to Immune Checkpoints. | Cancers (Basel) | 2022 | 36428727 | PubTator, text mining | PubMed |
| Macrophage M1 polarization mediated via the IL-6/STAT3 pathway contributes to apical periodontitis induced by Porphyromonas gingivalis. | J Appl Oral Sci | 2022 | 36417596 | PubTator, text mining | PubMed |
| Alzheimer's disease alters the transcriptomic profile of natural killer cells at single-cell resolution. | Front Immunol | 2022 | 36405736 | PubTator, text mining | PubMed |
| Whole-genome analysis of monozygotic Brazilian twins discordant for type 1 narcolepsy: a case report. | BMC Neurol | 2022 | 36401198 | PubTator, text mining | PubMed |
| PARP1 Is a Prognostic Marker and Targets NFATc2 to Promote Carcinogenesis in Melanoma. | Genet Test Mol Biomarkers | 2022 | 36394458 | PubTator, text mining | PubMed |
| Identification of a novel sepsis prognosis model and analysis of possible drug application prospects: Based on scRNA-seq and RNA-seq data. | Front Immunol | 2022 | 36389695 | PubTator, text mining | PubMed |
| Potentiating effect of reovirus on immune checkpoint inhibition in microsatellite stable colorectal cancer. | Front Oncol | 2022 | 36387154 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis reveals novel key biomarkers in diabetic nephropathy. | SAGE Open Med | 2022 | 36385790 | PubTator, text mining | PubMed |
| Regulation of B cell receptor signalling by Epstein-Barr virus nuclear antigens. | Biochem J | 2022 | 36383217 | PubTator, text mining | PubMed |
| Regulation of Cyclooxygenase-2 Expression in Human T Cells by Glucocorticoid Receptor-Mediated Transrepression of Nuclear Factor of Activated T Cells. | Int J Mol Sci | 2022 | 36362060 | PubTator, text mining | PubMed |
| The Role of HSP90 Inhibitors in the Treatment of Cardiovascular Diseases. | Cells | 2022 | 36359837 | PubTator, text mining | PubMed |
| Autotaxin in Breast Cancer: Role, Epigenetic Regulation and Clinical Implications. | Cancers (Basel) | 2022 | 36358855 | PubTator, text mining | PubMed |
| CIC-Rearranged Sarcomas: An Intriguing Entity That May Lead the Way to the Comprehension of More Common Cancers. | Cancers (Basel) | 2022 | 36358827 | PubTator, text mining | PubMed |
| Irreversible Electroporation Mediates Glioma Apoptosis via Upregulation of AP-1 and Bim: Transcriptome Evidence. | Brain Sci | 2022 | 36358391 | PubTator, text mining | PubMed |
| Repurposing Lenvatinib as A Potential Therapeutic Agent against Thyroid Eye Disease by Suppressing Adipogenesis in Orbital Adipose Tissues. | Pharmaceuticals (Basel) | 2022 | 36355477 | PubTator, text mining | PubMed |
| Identification of the common differentially expressed genes and pathogenesis between neuropathic pain and aging. | Front Neurosci | 2022 | 36340779 | PubTator, text mining | PubMed |
| ADAMTS6: Emerging roles in cardiovascular, musculoskeletal and cancer biology. | Front Mol Biosci | 2022 | 36339722 | PubTator, text mining | PubMed |
| Editorial: Are natural products, used as antitumoral/antiangiogenic agents, less toxic than synthetic conventional chemotherapy? | Front Pharmacol | 2022 | 36339558 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4773/papers?page=25